• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

GM CFO sees “more stable” chip supplies in 2022, reaffirms 2021 outlook

September 10, 2021 by David Barret Leave a Comment

September 10, 2021

DETROIT (Reuters) – General Motors Co Chief Financial Officer Paul Jacobson reaffirmed the automaker’s 2021 profit outlook and said the company expects a “more stable year” in 2022 for semiconductor supplies.

Jacobson said during a conference call with investors that GM still expects to deliver pre-tax profits for 2021 in the range of $11.5 billion to $13.5 billion forecast last month, and said 10% pre-tax margins for GM’s North American operations are “quite achievable” in 2022 even as the company ramps up investment in electric vehicles.

Despite the uncertainty created by the continuing pandemic and supply chain disruptions, Jacobson said GM “does not want to drive a level of COVID austerity into the business” and will not pull back its investment plans.

Jacobson cautioned that GM’s third quarter wholesale deliveries could be down by 200,000 vehicles because of chip shortages, and because GM shifted production into the second quarter as it managed semiconductor supplies.

Jacobson said GM expects to get reimbursed by electric vehicle battery partner LG Chem for costs related to the recent recall of Chevrolet Bolt EVs due to fires related to battery defects. GM has set aside $1.8 billion in total for the recall. Jacobson said GM and LG are in “high level conversations” about the division of costs.

(Reporting By Joe White)

Source Link GM CFO sees “more stable” chip supplies in 2022, reaffirms 2021 outlook

David Barret
David Barret

Related posts:

  1. Tennis-Raducanu surprises herself with U.S. Open run
  2. Printify bags $45M, led by Index, to ride the custom printing boom
  3. Cathay Pacific to close London pilot base, review U.S. bases
  4. Indian court stalls regulatory approval for Future’s $3.4 billion deal for 4 weeks

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • This Month’s New Moon Will Be The Farthest From Earth For The Next 18 Years
  • Playing Music To Baby Mice Shapes Their Brain Development In A Sex-Specific Way
  • Ice XXI: Scientists Discover A New Form Of Ice Born At Room Temperature Under Intense Pressure
  • Citizen Scientists Are Helping With Rescue Efforts In Hurricane Melissa’s Aftermath – Here’s How You Can Too
  • What Is The Radio Blackout Scale And When Is It Needed?
  • “It’s Alive!”: The Real (And Horrifying) Science That Inspired Mary Shelley’s Frankenstein
  • First-Ever View Of The Sun’s Polar Magnetic Field Reveals Major Surprise
  • A Killer Whale Birth Has Been Captured On Camera In The Wild For The First Time
  • If You Shine A Light In Your Garden And See Lots Of Dots Reflected Back, We’ve Got Bad News
  • The “Sailor’s Eyeball” Blob Is One Of The Largest Single-Celled Organisms Ever Discovered
  • Icefish Live In Sub-Zero Antarctic Waters, So Why Don’t They Freeze?
  • We Finally Know What Happened To The Stone Of Destiny
  • Meet The Fishing Cat: The World’s Most Aquatic Feline Has Evolved To Master The Wetlands
  • Why Is There A Mysterious White Pyramid In Arizona?
  • Humpback Hitchhickers: Watch POV Footage Of Suckerfish Clinging To Whales As They Migrate Across Oceans
  • Oldowan Tools Saw Early Humans Through 300,000 Years Of Fire, Drought, And Shifting Climates, New Site Reveals
  • There Are Just Two Places In The World With No Speed Limits For Cars
  • Three Astronauts Are Stranded In Space Again, After Their Ride Home Was Struck By Space Junk
  • Snail Fossils Over 1 Million Years Old Show Prehistoric Snails Gave Birth to Live Young
  • “Beautiful And Interesting”: Listen To One Of The World’s Largest Living Organisms As It Eerily Rumbles
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version